Advertisement
UK markets open in 1 hour 3 minutes
  • NIKKEI 225

    37,968.49
    +340.01 (+0.90%)
     
  • HANG SENG

    17,661.19
    +376.65 (+2.18%)
     
  • CRUDE OIL

    84.00
    +0.43 (+0.51%)
     
  • GOLD FUTURES

    2,347.70
    +5.20 (+0.22%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,580.14
    +210.51 (+0.41%)
     
  • CMC Crypto 200

    1,388.97
    +6.40 (+0.46%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

These Products Saw Falling Sales in Pfizer’s Q2 2018

These Products Saw Falling Sales in Pfizer’s Q2 2018

Pfizer’s (PFE) portfolio also includes a few products that are losing market share due to competition from other products in the market. These products include Enbrel (outside the United States and Canada), Sutent, Xalkori, BeneFix, Premarin Family, Medrol, Celebrex, Lyrica, and Viagra.